home / stock / blco / blco news


BLCO News and Press, Bausch + Lomb Corporation From 02/18/26

Stock Information

Company Name: Bausch + Lomb Corporation
Stock Symbol: BLCO
Market: NYSE
Website: bausch.com

Menu

BLCO BLCO Quote BLCO Short BLCO News BLCO Articles BLCO Message Board
Get BLCO Alerts

News, Short Squeeze, Breakout and More Instantly...

BLCO - Bausch + Lomb reports mixed results; initiates FY26outlook

2026-02-18 07:01:55 ET More on Bausch + Lomb Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Bausch + Lomb: I ...

BLCO - Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance

Delivered meaningful EBITDA margin expansion and operating leverage in the fourth quarter Fourth-Quarter 2025 Financial Results Revenue of $1.405 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $58 Million Adjusted EBITDA (non-GAAP) 1 of $3...

BLCO - Expected US Company Earnings on Wednesday, February 18th, 2026

OGE Energy Corp (OGE) is expected to report $0.3 for Q4 2025 Dana Incorporated (DAN) is expected to report $0.32 for Q4 2025 SiriusPoint Ltd. (SPNT) is expected to report $0.54 for Q4 2025 Nutrien Ltd. (NTR) is expected to report $0.82 for Q4 2025 Broadstone Net Lease Inc. (BNL) i...

BLCO - Moderating Growth Could Be A Tough Challenge For Cooper Shares

2026-02-13 07:42:57 ET The Cooper Companies ( COO ) (“Cooper”) is a case in point as to how you can, like, even admire, a company and yet not have particularly bullish feelings about the stock. Over the years, management has done a good job of leveraging product develo...

BLCO - BLCO Price Target Alert: $21.00. Issued by RBC Capital

2026-01-27 08:19:43 ET from RBC Capital issued a price target of $21.00 for BLCO on 2026-01-27 12:53:46. The adjusted price target was set to $21.00. At the time of the announcement, BLCO was trading at $16.87. The overall price target consensus is at $18.63 with high pr...

BLCO - Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2025 financial results on Wednesday, Feb. 18, 2026. The company will host a conference call and live webcast at 8 a....

BLCO - Bausch Health sets 2025 outlook at the higher end of the prior range

2026-01-13 10:54:37 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path Why Bausch Health Is A Buy After Rising 10% On ...

BLCO - Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-12 18:06:02 ET Bausch + Lomb Corporation (BLCO) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthca...

BLCO - Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.

Bausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma research Bausch + Lomb will also sponsor The Glaucoma Foundation’s annual month-long educational social med...

BLCO - Bausch + Lomb completes refinancing of outstanding term B loans

2026-01-02 16:52:07 ET More on Bausch + Lomb, Bausch Health Companies Bausch + Lomb: I Need To See Stability Before Upgrading This Name Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript Bau...

Previous 10 Next 10